What does the antibody cocktail approved by India contain and how does it work?
Team Udayavani, May 8, 2021, 1:00 PM IST
Pharma giant Roche India has received the Emergency Use Authorisation (EUA) for a COVID-19 antibody-drug cocktail in the country for the treatment of Covid-19 patients.
What is it?
Roche’s antibody cocktail contains two antibodies, casirivimab and imdevimab and is used for the treatment of mild-to-moderate Covid-19 in high-risk patients. It is developed by Roche and Regeneron.
Casirivimab and Imdevimab is approved at a combined dose of 1200 mg (600 mg of each drug) administered by intravenous infusion or subcutaneous route.
It has to be stored at 2°C to 8°C. Casirivimab and Imdevimab are human immunoglobulin G-1 (IgG1) monoclonal antibodies produced by recombinant DNA technology.
How does it work?
The antibodies are specifically directed against spike protein of SARS-CoV-2 and are designed to block virus’ attachment and entry into human cells. “The cocktail remains efficacious against widest spread variants,” Roche said.
The antibody treatment was administered to former US President Donald Trump after he was diagnosed with COVID-19.
Roche will import the antibody cocktail, which will be marketed and distributed in India via a strategic partnership with Cipla Ltd.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Study examines genetic basis for blood pressure, risk for hypertension
Why not detect sex of foetus, then protect girl child: IMA chief Asokan
Include 4 hrs of physical activity, 8 hrs sleep in routine for optimal health, suggests study
Traffic noise can increase risk of cardiovascular disease: Study
Nearsightedness is at epidemic levels – and the problem begins in childhood
MUST WATCH
Latest Additions
BJP can’t remain with those who commit atrocities against women: Amit Shah on Prajwal Revanna
Nothing will be left for future if held private properties material resources of community: SC
Amit Shah holds road show in Haveri ahead of Karnataka’s 2nd phase Lok Sabha polls
‘Markets may extend rally this month on strong domestic eco, current govt’s potential re-election’
Hoax bomb threat: Delhi government issues advisory for schools